Contemporary national surgical outcomes in the treatment of ureteropelvic junction obstruction

Daniel T. Oberlin, Barry B. McGuire, Matthew Pilecki, Aksharananda Rambachan, John Yah Sung Kim, Kent T Perry Jr, Robert B Nadler*

*Corresponding author for this work

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective To evaluate contemporary national trends and outcomes of open pyeloplasty (OP) vs minimally invasive pyeloplasty (MIP) in the treatment of ureteropelvic junction obstruction using the National Surgical Quality Improvement Program database. Methods Patients treated by OP or MIP between 2006 and 2011 were identified by The International Classification of Diseases, Ninth Revision, Clinical Modification codes corresponding to pyeloplasty as their primary operative procedure. Perioperative variables were analyzed using the chi-square and the Student t test. Multiple logistic regressions were used to identify morbidities and readmission risk factors. Results Three hundred fifty-five patients were identified. Of them, 20.2% of cases were OP and 79.8% were MIP. There was a significant increase in MIP from 33% in 2006 to 83% in 2011 (P <.001). A total of 11.7% of patients in the MIP group underwent outpatient surgery (P =.002). Patients treated at a teaching hospital were over 3 times more likely to undergo MIP (odds ratio = 3.17; P =.001). There was significantly longer hospitalization in OP vs MIP (3.9 vs 2.2 days; P =.001). OP was associated with significantly increased risk of reoperation or postoperative morbidity compared with MIP (11.1% vs 4.2%; P =.02). Multivariate analysis confirmed a higher rate of overall morbidity in the OP cohort (P =.03). Male patients had significantly higher postoperative morbidity or reoperation rates (odds ratio = 4.38; P =.002). There was no significant difference in operative time between groups (P =.2). Conclusion Within the American College of Surgeons National Surgical Quality Improvement Program hospitals, MIP is associated with decreased reoperation and postoperative morbidity compared with OP.

Original languageEnglish (US)
Pages (from-to)363-367
Number of pages5
JournalUrology
Volume85
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

Morbidity
Reoperation
Quality Improvement
Odds Ratio
Operative Surgical Procedures
International Classification of Diseases
Operative Time
Ambulatory Surgical Procedures
Teaching Hospitals
Hospitalization
Multivariate Analysis
Logistic Models
Databases
Students
Therapeutics

ASJC Scopus subject areas

  • Urology
  • Medicine(all)

Cite this

Oberlin, Daniel T. ; McGuire, Barry B. ; Pilecki, Matthew ; Rambachan, Aksharananda ; Kim, John Yah Sung ; Perry Jr, Kent T ; Nadler, Robert B. / Contemporary national surgical outcomes in the treatment of ureteropelvic junction obstruction. In: Urology. 2015 ; Vol. 85, No. 2. pp. 363-367.
@article{3d7e691d383b4f71982e013eb6254f69,
title = "Contemporary national surgical outcomes in the treatment of ureteropelvic junction obstruction",
abstract = "Objective To evaluate contemporary national trends and outcomes of open pyeloplasty (OP) vs minimally invasive pyeloplasty (MIP) in the treatment of ureteropelvic junction obstruction using the National Surgical Quality Improvement Program database. Methods Patients treated by OP or MIP between 2006 and 2011 were identified by The International Classification of Diseases, Ninth Revision, Clinical Modification codes corresponding to pyeloplasty as their primary operative procedure. Perioperative variables were analyzed using the chi-square and the Student t test. Multiple logistic regressions were used to identify morbidities and readmission risk factors. Results Three hundred fifty-five patients were identified. Of them, 20.2{\%} of cases were OP and 79.8{\%} were MIP. There was a significant increase in MIP from 33{\%} in 2006 to 83{\%} in 2011 (P <.001). A total of 11.7{\%} of patients in the MIP group underwent outpatient surgery (P =.002). Patients treated at a teaching hospital were over 3 times more likely to undergo MIP (odds ratio = 3.17; P =.001). There was significantly longer hospitalization in OP vs MIP (3.9 vs 2.2 days; P =.001). OP was associated with significantly increased risk of reoperation or postoperative morbidity compared with MIP (11.1{\%} vs 4.2{\%}; P =.02). Multivariate analysis confirmed a higher rate of overall morbidity in the OP cohort (P =.03). Male patients had significantly higher postoperative morbidity or reoperation rates (odds ratio = 4.38; P =.002). There was no significant difference in operative time between groups (P =.2). Conclusion Within the American College of Surgeons National Surgical Quality Improvement Program hospitals, MIP is associated with decreased reoperation and postoperative morbidity compared with OP.",
author = "Oberlin, {Daniel T.} and McGuire, {Barry B.} and Matthew Pilecki and Aksharananda Rambachan and Kim, {John Yah Sung} and {Perry Jr}, {Kent T} and Nadler, {Robert B}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.urology.2014.07.068",
language = "English (US)",
volume = "85",
pages = "363--367",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "2",

}

Contemporary national surgical outcomes in the treatment of ureteropelvic junction obstruction. / Oberlin, Daniel T.; McGuire, Barry B.; Pilecki, Matthew; Rambachan, Aksharananda; Kim, John Yah Sung; Perry Jr, Kent T; Nadler, Robert B.

In: Urology, Vol. 85, No. 2, 01.01.2015, p. 363-367.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Contemporary national surgical outcomes in the treatment of ureteropelvic junction obstruction

AU - Oberlin, Daniel T.

AU - McGuire, Barry B.

AU - Pilecki, Matthew

AU - Rambachan, Aksharananda

AU - Kim, John Yah Sung

AU - Perry Jr, Kent T

AU - Nadler, Robert B

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objective To evaluate contemporary national trends and outcomes of open pyeloplasty (OP) vs minimally invasive pyeloplasty (MIP) in the treatment of ureteropelvic junction obstruction using the National Surgical Quality Improvement Program database. Methods Patients treated by OP or MIP between 2006 and 2011 were identified by The International Classification of Diseases, Ninth Revision, Clinical Modification codes corresponding to pyeloplasty as their primary operative procedure. Perioperative variables were analyzed using the chi-square and the Student t test. Multiple logistic regressions were used to identify morbidities and readmission risk factors. Results Three hundred fifty-five patients were identified. Of them, 20.2% of cases were OP and 79.8% were MIP. There was a significant increase in MIP from 33% in 2006 to 83% in 2011 (P <.001). A total of 11.7% of patients in the MIP group underwent outpatient surgery (P =.002). Patients treated at a teaching hospital were over 3 times more likely to undergo MIP (odds ratio = 3.17; P =.001). There was significantly longer hospitalization in OP vs MIP (3.9 vs 2.2 days; P =.001). OP was associated with significantly increased risk of reoperation or postoperative morbidity compared with MIP (11.1% vs 4.2%; P =.02). Multivariate analysis confirmed a higher rate of overall morbidity in the OP cohort (P =.03). Male patients had significantly higher postoperative morbidity or reoperation rates (odds ratio = 4.38; P =.002). There was no significant difference in operative time between groups (P =.2). Conclusion Within the American College of Surgeons National Surgical Quality Improvement Program hospitals, MIP is associated with decreased reoperation and postoperative morbidity compared with OP.

AB - Objective To evaluate contemporary national trends and outcomes of open pyeloplasty (OP) vs minimally invasive pyeloplasty (MIP) in the treatment of ureteropelvic junction obstruction using the National Surgical Quality Improvement Program database. Methods Patients treated by OP or MIP between 2006 and 2011 were identified by The International Classification of Diseases, Ninth Revision, Clinical Modification codes corresponding to pyeloplasty as their primary operative procedure. Perioperative variables were analyzed using the chi-square and the Student t test. Multiple logistic regressions were used to identify morbidities and readmission risk factors. Results Three hundred fifty-five patients were identified. Of them, 20.2% of cases were OP and 79.8% were MIP. There was a significant increase in MIP from 33% in 2006 to 83% in 2011 (P <.001). A total of 11.7% of patients in the MIP group underwent outpatient surgery (P =.002). Patients treated at a teaching hospital were over 3 times more likely to undergo MIP (odds ratio = 3.17; P =.001). There was significantly longer hospitalization in OP vs MIP (3.9 vs 2.2 days; P =.001). OP was associated with significantly increased risk of reoperation or postoperative morbidity compared with MIP (11.1% vs 4.2%; P =.02). Multivariate analysis confirmed a higher rate of overall morbidity in the OP cohort (P =.03). Male patients had significantly higher postoperative morbidity or reoperation rates (odds ratio = 4.38; P =.002). There was no significant difference in operative time between groups (P =.2). Conclusion Within the American College of Surgeons National Surgical Quality Improvement Program hospitals, MIP is associated with decreased reoperation and postoperative morbidity compared with OP.

UR - http://www.scopus.com/inward/record.url?scp=84921449142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921449142&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2014.07.068

DO - 10.1016/j.urology.2014.07.068

M3 - Article

VL - 85

SP - 363

EP - 367

JO - Urology

JF - Urology

SN - 0090-4295

IS - 2

ER -